The Affordable Insulin Now Act (hr6833-117) caps patient cost-sharing for insulin products at $35 monthly under private insurance and Medicare, directly regulating the Pharmaceuticals & Biotech industry. Rep. Angie Craig (D-MN) introduced this bill. Pharmaceuticals & Biotech represents 2.8% of Craig's identifiable donor base ($0.47M), ranking #46 among Democratic recipients in this industry sector.

FOLLOW THE TRAIL
How we built this: a statistical pattern surfaced from public records — FEC campaign finance, Senate/House Lobbying Disclosure Act filings, and Congress.gov. The donor concentration and the legislative action are concurrent facts; this does not imply contributions caused the action, that the member acted improperly, or that the bill specifically benefits the named sector. Generated June 30, 2026 · internal signal score 47/100.